A Real-World Study of Deucravacitinib for the Treatment of Chinese Patients with Moderate-to-Severe Plaque Psoriasis (ChiCTR) - Sep 16, 2026 - P4 | N=100 | Not yet recruiting | Sponsor: Department of Dermatology, The First Affiliated Hospital of Air Force Medical University; The First Affiliated Hospital of Air Force Medical Universit
New P4 trial • Real-world evidence • Dermatology • Immunology • Psoriasis
|